标题
New drug approvals for 2020: Synthesis and clinical applications
作者
关键词
New drugs, Chemical synthesis, Clinical applications
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 215, Issue -, Pages 113284
出版商
Elsevier BV
发表日期
2021-02-15
DOI
10.1016/j.ejmech.2021.113284
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2020 FDA drug approvals
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Avapritinib: First Approval
- (2020) Sohita Dhillon DRUGS
- Osilodrostat: First Approval
- (2020) Sean Duggan DRUGS
- Actinic keratosis: where do we stand and where is the future going to take us?
- (2020) Philipp Cramer et al. EXPERT OPINION ON EMERGING DRUGS
- An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting
- (2020) Natalia Smyla et al. EXPERT OPINION ON PHARMACOTHERAPY
- 2019 FDA drug approvals
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
- (2020) O. Metzger et al. ANNALS OF ONCOLOGY
- Oral cedazuridine/decitabine: a phase 2, pharmacokinetic/pharmacodynamic, randomized, crossover study in MDS and CMML
- (2020) Guillermo Garcia-Manero et al. BLOOD
- New techniques and strategies in drug discovery
- (2020) Jintong Du et al. CHINESE CHEMICAL LETTERS
- Clascoterone as a novel treatment for androgenetic alopecia
- (2020) H.Y. Sun et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Remimazolam: First Approval
- (2020) Susan J. Keam DRUGS
- Eptinezumab: First Approval
- (2020) Sohita Dhillon DRUGS
- Bempedoic Acid: First Approval
- (2020) Anthony Markham DRUGS
- Rimegepant: First Approval
- (2020) Lesley J. Scott DRUGS
- Teprotumumab: First Approval
- (2020) Anthony Markham DRUGS
- Ozanimod: First Approval
- (2020) Yvette N. Lamb DRUGS
- Tazemetostat: First Approval
- (2020) Sheridan M. Hoy DRUGS
- Pemigatinib: First Approval
- (2020) Sheridan M. Hoy DRUGS
- Medicinal chemistry insights into novel CDC25 inhibitors
- (2020) Yucen Tao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Relugolix: Early Promise for a Novel Oral Androgen Deprivation Therapy with Radiation Therapy for Prostate Cancer
- (2020) Sean Sachdev et al. EUROPEAN UROLOGY
- HERO phase III trial: Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer.
- (2020) Neal D. Shore et al. JOURNAL OF CLINICAL ONCOLOGY
- Open-Label, Long-Term Extension Study to Evaluate the Safety of Clascoterone (CB-03-01) Cream, 1% BID in Subjects with Acne Vulgaris
- (2020) Lawrence Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Benefit from pemigatinib in cholangiocarcinoma
- (2020) Diana Romero Nature Reviews Clinical Oncology
- FDA new drug approvals in Q1 2020
- (2020) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Selumetinib in Children with Inoperable Plexiform Neurofibromas
- (2020) Andrea M. Gross et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
- (2020) Michael Kozal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir in covid-19
- (2020) Robin E Ferner et al. BMJ-British Medical Journal
- Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne
- (2020) Adelaide Hebert et al. JAMA Dermatology
- A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting
- (2020) Gabriel Fox et al. Expert Review of Clinical Pharmacology
- Remimazolam for anaesthesia or sedation
- (2020) J. Robert Sneyd et al. Current Opinion in Anesthesiology
- Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
- (2020) Robert Haws et al. DIABETES OBESITY & METABOLISM
- Tucatinib: First Approval
- (2020) Arnold Lee DRUGS
- Selumetinib: First Approval
- (2020) Anthony Markham et al. DRUGS
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Sacituzumab Govitecan: First Approval
- (2020) Yahiya Y. Syed DRUGS
- Selpercatinib: First Approval
- (2020) Anthony Markham DRUGS
- Capmatinib: First Approval
- (2020) Sohita Dhillon DRUGS
- Ripretinib: First Approval
- (2020) Sohita Dhillon DRUGS
- New Drug Approvals for 2019: Synthesis and Clinical Applications
- (2020) Shuo Yuan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Beneficial effects of lactitol on the composition of gut microbiota in constipated patients
- (2020) Xiao Qing Li et al. Journal of Digestive Diseases
- FDA new drug approvals in Q2 2020
- (2020) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Enhancing the antimalarial activity of artesunate
- (2020) J. O. Adebayo et al. PARASITOLOGY RESEARCH
- Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
- (2020) Rosario Pivonello et al. Lancet Diabetes & Endocrinology
- Cost-Effectiveness of Tucatinib in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer From the US and Chinese Perspectives
- (2020) Qiuji Wu et al. Frontiers in Oncology
- Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS
- (2020) Sarah Harris et al. Neurology-Neuroimmunology & Neuroinflammation
- Overcoming MET-dependent resistance to selective RET inhibition in patients with RET fusion-positive lung cancer by combining selpercatinib with crizotinib
- (2020) Ezra Y Rosen et al. CLINICAL CANCER RESEARCH
- Remdesivir: First Approval
- (2020) Yvette N. Lamb DRUGS
- Risdiplam: First Approval
- (2020) Sohita Dhillon DRUGS
- Oliceridine: First Approval
- (2020) Anthony Markham DRUGS
- Lurbinectedin: First Approval
- (2020) Anthony Markham DRUGS
- Decitabine/Cedazuridine: First Approval
- (2020) Sohita Dhillon DRUGS
- Fostemsavir: First Approval
- (2020) Anthony Markham DRUGS
- Belantamab Mafodotin: First Approval
- (2020) Anthony Markham DRUGS
- Triheptanoin: First Approval
- (2020) Matt Shirley DRUGS
- Clascoterone: First Approval
- (2020) Sohita Dhillon DRUGS
- Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma
- (2020) Valeria Merz et al. Future Oncology
- Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial
- (2020) Bruce Zuraw et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
- (2020) Mrinal Gounder et al. LANCET ONCOLOGY
- FDA new drug approvals in Q3 2020
- (2020) Lisa Urquhart NATURE REVIEWS DRUG DISCOVERY
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
- (2020) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to avapritinib in PDGFRA-driven GIST is caused by secondary mutations in the PDGFRA kinase domain
- (2020) Susanne Grunewald et al. Cancer Discovery
- Antagonism of CGRP Signaling by Rimegepant at Two Receptors
- (2020) Kylie S. Pan et al. Frontiers in Pharmacology
- Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations
- (2020) V. Subbiah et al. ANNALS OF ONCOLOGY
- 2018 FDA drug approvals
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014–2018 update)
- (2019) Ruifang Jia et al. Future Medicinal Chemistry
- A Scalable Total Synthesis of the Antitumor Agents Et-743 and Lurbinectedin
- (2019) Weiming He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
- (2019) Bryan D. Smith et al. CANCER CELL
- Relugolix: First Global Approval
- (2019) Anthony Markham DRUGS
- Osilodrostat is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing’s Syndrome: an in Vitro Study
- (2019) S G Creemers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overview of Recent Strategic Advances in Medicinal Chemistry
- (2019) Gaochan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study
- (2019) Michael R Savona et al. Lancet Haematology
- Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors
- (2019) Xia Hao et al. Expert Opinion on Drug Discovery
- Rimegepant oral disintegrating tablet for migraine
- (2019) Lars Edvinsson LANCET
- Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite
- (2019) Deepika Kannan et al. EBioMedicine
- Capmatinib for the treatment of non-small cell lung cancer
- (2019) Johan Filip Vansteenkiste et al. Expert Review of Anticancer Therapy
- Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
- (2019) Wei Xie et al. OncoImmunology
- Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity
- (2019) Lu Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome
- (2019) Elodie Hainque et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Determinants of post-malarial anemia in African children treated with parenteral artesunate
- (2019) Katrin Scheu et al. Scientific Reports
- Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk
- (2018) Peter Kranke et al. ANESTHESIOLOGY
- Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail
- (2018) C. Crespillo-Andújar et al. CLINICAL MICROBIOLOGY AND INFECTION
- Vibegron, a Novel Potent and Selective β 3 -Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study
- (2018) Masaki Yoshida et al. EUROPEAN UROLOGY
- A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy
- (2018) Douglas K. Rex et al. GASTROINTESTINAL ENDOSCOPY
- Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome
- (2018) Leslie B. Gordon et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Pharmacophore Network: A Computational Method for Exploring Structure–Activity Relationships from a Large Chemical Data Set
- (2018) Jean-Philippe Métivier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir
- (2018) Tao Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Use of artesunate in non-malarial indications
- (2018) A. Raffetin et al. MEDECINE ET MALADIES INFECTIEUSES
- Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation
- (2018) Vernon M. Bowles et al. PEDIATRIC DERMATOLOGY
- Pharmacological Characters of Oliceridine, a μ-Opioid Receptor G-Protein[FIGURE DASH]Biased Ligand in Mice
- (2018) De-Yong Liang et al. ANESTHESIA AND ANALGESIA
- Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
- (2018) Hasane Ratni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead-like Drugs: A Perspective
- (2018) Brian Raymer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preliminary activity of capmatinib with gefitinib in NSCLC
- (2018) Talha Khan Burki LANCET ONCOLOGY
- Lurbinectedin for BRCA-mutated advanced breast cancer
- (2018) Elizabeth Gourd LANCET ONCOLOGY
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Artificial intelligence in drug design
- (2018) Feisheng Zhong et al. Science China-Life Sciences
- Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
- (2018) Yemarshet K. Gebreyohannes et al. CLINICAL CANCER RESEARCH
- Vibegron: First Global Approval
- (2018) Susan J. Keam DRUGS
- Bempedoic acid
- (2018) Amy C. Burke et al. CURRENT OPINION IN LIPIDOLOGY
- Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
- (2017) Nicholas A. Meanwell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Triheptanoin for the treatment of brain energy deficit: A 14-year experience
- (2017) Fanny Mochel JOURNAL OF NEUROSCIENCE RESEARCH
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Andrew J. Lees et al. JAMA Neurology
- Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
- (2017) Tinh-Hai Collet et al. Molecular Metabolism
- How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways
- (2016) Sebastian Schneider et al. BIOCHEMISTRY
- Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist
- (2016) Jocelyn M Bischof et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeClinical Perspective
- (2016) Leslie B. Gordon et al. CIRCULATION
- Opicapone: A Review in Parkinson’s Disease
- (2016) Lesley J. Scott DRUGS
- Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells
- (2016) Silvina Grasso et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ovicidal Efficacy of Abametapir Against Eggs of Human Head and Body Lice (Anoplura: Pediculidae)
- (2016) Vernon M. Bowles et al. JOURNAL OF MEDICAL ENTOMOLOGY
- The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
- (2016) Kevin W. Kuntz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder
- (2016) Scott D. Edmondson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology
- (2016) Alexandra M. Wesolowski et al. PHARMACOTHERAPY
- Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors
- (2015) Lidan Zhang et al. RSC Advances
- Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine Deaminase
- (2014) Dana Ferraris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder
- (2014) Christopher R. Moyes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain
- (2013) Xiao-Tao Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reductive Couplings of 2-Halopyridines without External Ligand: Phosphine-Free Nickel-Catalyzed Synthesis of Symmetrical and Unsymmetrical 2,2′-Bipyridines
- (2013) Lian-Yan Liao et al. JOURNAL OF ORGANIC CHEMISTRY
- Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment
- (2013) N. J. Ullrich et al. NEUROLOGY
- Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors
- (2013) Erik L. Meredith et al. ACS Medicinal Chemistry Letters
- Synthesis of triheptanoin and formulation as a solid diet for rodents
- (2012) Vladislav Semak et al. EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
- Lonafarnib for cancer and progeria
- (2012) Nan Soon Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine
- (2012) Guanglin Luo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease
- (2010) Yves Jackson et al. CLINICAL INFECTIOUS DISEASES
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started